Mira Pharmaceuticals to Acquire Bio-Genetics, Inc.
Ticker: MIRA · Form: 8-K · Filed: Jul 19, 2024 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Jul 19, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, biotechnology, merger
TL;DR
Mira Pharma buying Bio-Genetics to boost pipeline, closing Q3.
AI Summary
Mira Pharmaceuticals, Inc. announced on July 19, 2024, that it has entered into a definitive agreement to acquire all outstanding equity interests in Bio-Genetics, Inc. The acquisition is expected to close in the third quarter of 2024, subject to customary closing conditions. This strategic move aims to expand Mira Pharmaceuticals' product pipeline and market reach.
Why It Matters
This acquisition could significantly expand Mira Pharmaceuticals' product offerings and market presence in the biotechnology sector.
Risk Assessment
Risk Level: medium — Acquisitions carry inherent risks, including integration challenges and potential overvaluation, which could impact Mira Pharmaceuticals' financial performance.
Key Players & Entities
- Mira Pharmaceuticals, Inc. (company) — Registrant
- Bio-Genetics, Inc. (company) — Target company for acquisition
- July 19, 2024 (date) — Date of the announcement and definitive agreement
- third quarter of 2024 (date) — Expected closing period for the acquisition
FAQ
What is the primary purpose of the acquisition of Bio-Genetics, Inc. by Mira Pharmaceuticals, Inc.?
The acquisition is intended to expand Mira Pharmaceuticals' product pipeline and market reach.
When is the acquisition of Bio-Genetics, Inc. expected to be completed?
The acquisition is expected to close in the third quarter of 2024.
What are the conditions for the closing of the Bio-Genetics, Inc. acquisition?
The closing is subject to customary closing conditions.
What was Mira Pharmaceuticals, Inc.'s former name?
Mira Pharmaceuticals, Inc.'s former name was Mira1a Therapeutics, Inc.
In which state is Mira Pharmaceuticals, Inc. incorporated?
Mira Pharmaceuticals, Inc. is incorporated in Florida.
Filing Stats: 845 words · 3 min read · ~3 pages · Grade level 15 · Accepted 2024-07-19 17:12:01
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MIRA The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 39KB
- 0001493152-24-028548.txt ( ) — 212KB
- mira-20240719.xsd (EX-101.SCH) — 3KB
- mira-20240719_lab.xml (EX-101.LAB) — 33KB
- mira-20240719_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIRA PHARMACEUTICALS, INC. Date: July 19, 2024 By: /s/ Erez Aminov Erez Aminov Chief Executive Officer